Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Fuller

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Canadian Journal of Microbiology|December 1, 1982
Tetrapyrrole utilization of Bacteroides fragilisM D Fuller, D R Caldwell
Protein Expression and Purification|January 7, 1998
Expression of the catalytic subunit (UL54) and the accessory protein (UL44) of human cytomegalovirus DNA polymerase in a coupled in vitro transcription/translation systemT Cihlar, M D Fuller, J M Cherrington
Journal of Virology|June 17, 1998
Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragmentsT Cihlar, M D Fuller, J M Cherrington
Virology|August 29, 1998
A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell cultureT Cihlar, M D Fuller, A S Mulato, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1996
Novel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitroJ M Cherrington, A S Mulato, M D Fuller, et al.
Molecular Pharmacology|August 27, 1999
The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1T Cihlar, D C Lin, J B Pritchard, et al.
The Journal of Infectious Diseases|July 1, 1997
High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genesI L Smith, J M Cherrington, R E Jiles, et al.
The Journal of Infectious Diseases|November 17, 1998
In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcomeJ M Cherrington, M D Fuller, P D Lamy, et al.
The Journal of Membrane Biology|April 6, 2006
Inhibition of ClC-2 chloride channels by a peptide component or components of scorpion venomC H Thompson, D M Fields, P R Olivetti, et al.
Molecular Pharmacology|August 4, 1998
Human immunodeficiency virus type 1 reverse transcriptase expressing the K70E mutation exhibits a decrease in specific activity and processivityM D Miller, P D Lamy, M D Fuller, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Canadian Journal of Microbiology|December 1, 1982
Tetrapyrrole utilization of Bacteroides fragilisM D Fuller, D R Caldwell
Protein Expression and Purification|January 7, 1998
Expression of the catalytic subunit (UL54) and the accessory protein (UL44) of human cytomegalovirus DNA polymerase in a coupled in vitro transcription/translation systemT Cihlar, M D Fuller, J M Cherrington
Journal of Virology|June 17, 1998
Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragmentsT Cihlar, M D Fuller, J M Cherrington
Virology|August 29, 1998
A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell cultureT Cihlar, M D Fuller, A S Mulato, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1996
Novel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitroJ M Cherrington, A S Mulato, M D Fuller, et al.
Molecular Pharmacology|August 27, 1999
The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1T Cihlar, D C Lin, J B Pritchard, et al.
The Journal of Infectious Diseases|July 1, 1997
High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genesI L Smith, J M Cherrington, R E Jiles, et al.
The Journal of Infectious Diseases|November 17, 1998
In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcomeJ M Cherrington, M D Fuller, P D Lamy, et al.
The Journal of Membrane Biology|April 6, 2006
Inhibition of ClC-2 chloride channels by a peptide component or components of scorpion venomC H Thompson, D M Fields, P R Olivetti, et al.
Molecular Pharmacology|August 4, 1998
Human immunodeficiency virus type 1 reverse transcriptase expressing the K70E mutation exhibits a decrease in specific activity and processivityM D Miller, P D Lamy, M D Fuller, et al.
Pageof 2